Member Login
  1. Authors
    2. /
  2. Bilaal Mohamed
    3. /

Bilaal Mohamed

Bilaal Mohamed is a UK-based financial journalist who writes for The Motley Fool as well as offering his own independent analysis and recommendations. His articles are regularly published on prominent financial websites in the UK and overseas. Please be aware that all views expressed are Bilaal's own opinions and do not constitute investment advice.

Recent Articles

Investing Articles

2 FTSE 100 growth stocks I’d buy before it’s too late

| Bilaal Mohamed

Bilaal Mohamed explains why these two FTSE 100 (INDEXFTSE: UKX) shares could be about to surge.

Read more »

Investing Articles

2 FTSE 100 giants to consider buying before it’s too late

| Bilaal Mohamed

Bilaal Mohamed takes a closer look at two attractively-priced multinationals from the FTSE 100 (INDEXFTSE:UKX).

Read more »

Investing Articles

This tasty growth stock could soar 30% by 2018

| Bilaal Mohamed

Bilaal Mohamed identifies a tasty growth stock that could deliver 30% gains over the coming year.

Read more »

Investing Articles

2 dependable shares to retire on

| Bilaal Mohamed

Bilaal Mohamed reveals two perfect picks for long-term income investors.

Read more »

Investing Articles

Why I love these hated FTSE 100 shares

| Bilaal Mohamed

Bilaal Mohamed spots an opportunity in these out-of-fashion FTSE 100 (INDEXFTSE:UKX) stocks.

Read more »

Investing Articles

2 beaten-down FTSE 250 shares with spectacular turnaround potential

| Bilaal Mohamed

Bilaal Mohamed identifies two FTSE 250 (INDEXFTSE:MCX) battered shares with significant recovery potential.

Read more »

Investing Articles

2 bargain stocks I’d buy right now

| Bilaal Mohamed

Bilaal Mohamed uncovers two mid-cap shares with irresistible valuations.

Read more »

Investing Articles

Why I’m avoiding these exciting growth shares right now

| Bilaal Mohamed

Bilaal Mohamed explains why investors should wait before buying these growth stocks.

Read more »

Investing Articles

2 ‘secret’ income stocks with monster dividends

| Bilaal Mohamed

Bilaal Mohamed uncovers two hidden income shares with massive dividend payouts.

Read more »

Investing Articles

This stock has a 6.4% dividend with plenty of room to grow

| Bilaal Mohamed

Bilaal Mohamed unveils a top income stock with potential for strong dividend growth.

Read more »

Investing Articles

2 growth stocks to fall in love with

| Bilaal Mohamed

Bilaal Mohamed reveals his top growth picks for Valentine's Day and beyond.

Read more »

Investing Articles

Why this isn’t the time to be selling BT Group plc

| Bilaal Mohamed

Bilaal Mohamed explains why investors shouldn't panic in the aftermath of the recent accounting scandal.

Read more »

Investing Articles

This FTSE 100 stock has spectacular turnaround potential

| Bilaal Mohamed

Bilaal Mohamed discovers a beaten-down blue-chip stock with significant recovery potential.

Read more »

Investing Articles

2 bargain shares for under £2

| Bilaal Mohamed

Bilaal Mohamed takes a closer look at two of the cheapest shares available in the FTSE 250 (INDEXFTSE:MCX).

Read more »

Investing Articles

Why I see 40% upside in this turnaround stock in 2017

| Bilaal Mohamed

Bilaal Mohamed identifies a turnaround stock that could deliver 40% gains over the next 12 months.

Read more »

Investing Articles

2 high-yield dividend stocks I’d buy right now

| Bilaal Mohamed

Bilaal Mohamed explains why now could be a great time to buy these two generous income stocks.

Read more »

Investing Articles

After 11-bagging in under 5 years, this growth stock has further to run

| Bilaal Mohamed

Bilaal Mohamed looks at a British sports retailer whose shares have risen 1,193% in less than five years.

Read more »

Investing Articles

2 top dividend stocks I’d buy in February

| Bilaal Mohamed

Bilaal Mohamed reveals two of his top dividend buys for the month of February.

Read more »

Investing Articles

Are these high-flyers heading for a crash?

| Bilaal Mohamed

Bilaal Mohamed considers whether these two soaring shares could be heading for a crash.

Read more »

Investing Articles

2 ‘hot’ growth shares I’d buy in February

| Bilaal Mohamed

Bilaal Mohamed explains why February could be a good time to buy these exciting growth stocks.

Read more »

Investing Articles

One growth stock I’d add and one I’d avoid in 2017

| Bilaal Mohamed

Bilaal Mohamed picks out one stock that could yield rich rewards and one that looks too expensive 2017.

Read more »

Investing Articles

2 top dividend stocks selling for a discount this winter

| Bilaal Mohamed

Bilaal Mohamed explains why it could be a good time to pick up these generous dividend payers.

Read more »

Investing Articles

GROWTH! Wait – don’t buy these shares just yet…

| Bilaal Mohamed

Bilaal Mohamed explains why now is perhaps NOT the best time to buy these growth shares.

Read more »

Investing Articles

2 ‘hidden’ income stocks for 2017 and beyond

| Bilaal Mohamed

Bilaal Mohamed discovers two mid-cap shares with attractive levels of dividend growth.

Read more »

Investing Articles

This retailer could be a top recovery play in 2017

| Bilaal Mohamed

Bilaal Mohamed reveals one of his top recovery plays for 2017.

Read more »

Investing Articles

This 8% yield could be a top dividend buy for 2017

| Bilaal Mohamed

Bilaal Mohamed reveals one of his top dividend buys for the year ahead.

Read more »

Investing Articles

Why I’m avoiding this high-yielding stock right now

| Bilaal Mohamed

Bilaal Mohamed says investors should think carefully before piling-in to this troubled firm.

Read more »

Investing Articles

This FTSE 100 growth stock could be set to soar

| Bilaal Mohamed

Bilaal Mohamed discovers an unmissable growth share from the FTSE 100 (INDEXFTSE:UKX).

Read more »

Investing Articles

Why I see 50% upside in this pharmaceutical firm in 2017

| Bilaal Mohamed

Bilaal Mohamed explains why this pharamceutical firm could have massive growth potential over the coming year.

Read more »

Investing Articles

2 airline stocks worth buying in 2017

| Bilaal Mohamed

Bilaal Mohamed explains why these two low-cost airlines could go far this year.

Read more »

Investing Articles

2 top dividend aristocrats I’d buy in January

| Bilaal Mohamed

Bilaal Mohamed takes a closer look at two popular income shares from among the blue-chip elite.

Read more »

Investing Articles

Is this your last chance to buy National Grid plc under £10?

| Bilaal Mohamed

Bilaal Mohamed explains why buying National Grid plc (LON: NG) at its current price could boost your portfolio.

Read more »

Investing Articles

Is it too late to buy these FTSE 100 high-flyers?

| Bilaal Mohamed

Bilaal Mohamed asks whether it's too late to buy these soaring shares from the FTSE 100 (INDEXFTSE:UKX).

Read more »

Investing Articles

2 ‘hot’ growth shares I’d buy in January

| Bilaal Mohamed

Bilaal Mohamed explains why January could be a good time to buy these exciting growth stocks.

Read more »

Investing Articles

3 FTSE 100 bargains for under £3

| Bilaal Mohamed

Bilaal Mohamed takes a closer look at three of the cheapest shares available in the FTSE 100 (INDEXFTSE:UKX).

Read more »

Investing Articles

2 income stocks for a more comfortable retirement

| Bilaal Mohamed

Bilaal Mohamed looks at two dividend favourites that should provide passive income for many years to come.

Read more »

Investing Articles

2 top chemical firms for growth investors right now

| Bilaal Mohamed

Bilaal Mohamed explains why these two chemical firms could be poised for big gains in the coming months.

Read more »

Investing Articles

Beat the January sales with these blue-chip bargains

| Bilaal Mohamed

Bilaal Mohamed spots two blue-chip bargains that could post healthy gains in 2017.

Read more »

dividend scrabble piece spelling
Investing Articles

2 ‘secret’ income stocks to help you grow richer in 2017

| Bilaal Mohamed

Bilaal Mohamed uncovers two under-the-radar income stocks with growing dividends.

Read more »

Investing Articles

Kick-start 2017 with these explosive growth stocks

| Bilaal Mohamed

Bilaal Mohamed thinks these two pharmacetutical firms could be on the verge of spectacular gains in 2017.

Read more »